AU1582495A - Recombinant baculovirus and use thereof in the production of monoclonal antibodies - Google Patents

Recombinant baculovirus and use thereof in the production of monoclonal antibodies

Info

Publication number
AU1582495A
AU1582495A AU15824/95A AU1582495A AU1582495A AU 1582495 A AU1582495 A AU 1582495A AU 15824/95 A AU15824/95 A AU 15824/95A AU 1582495 A AU1582495 A AU 1582495A AU 1582495 A AU1582495 A AU 1582495A
Authority
AU
Australia
Prior art keywords
production
promotors
recombinant baculovirus
monoclonal antibodies
baculovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15824/95A
Inventor
Martine Cerutti
Hassan Chaabihi
Gerard Devauchelle
Laurent Gauthier
Michel Kaczorek
Marie-Paule Lefranc
Marie-Alix Poul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteine Performance
Original Assignee
Proteine Performance
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteine Performance filed Critical Proteine Performance
Publication of AU1582495A publication Critical patent/AU1582495A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Recombinant baculovirus used as an expression vector in the production of immunoglobulins within an insect cell. The invention is characterized by an expression cassette comprising a sequence coding for at least one portion of an immunoglobin H chain, said sequence being transcriptionally controlled by a first baculovirus promotor, and an expression cassette comprising a sequence coding for at least one portion of an immunoglobin L chain, said sequence being transcriptionally controlled by a second baculovirus promotor. The first and second promotors are two different promotors or derivatives of different promotors, the first and second promotors residing in different loci.
AU15824/95A 1994-01-31 1995-01-31 Recombinant baculovirus and use thereof in the production of monoclonal antibodies Abandoned AU1582495A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9401015A FR2715664B1 (en) 1994-01-31 1994-01-31 Recombinant baculovirus and its use for the production of monoclonal antibodies.
FR9401015 1994-01-31
PCT/FR1995/000110 WO1995020672A1 (en) 1994-01-31 1995-01-31 Recombinant baculovirus and use thereof in the production of monoclonal antibodies

Publications (1)

Publication Number Publication Date
AU1582495A true AU1582495A (en) 1995-08-15

Family

ID=9459563

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15824/95A Abandoned AU1582495A (en) 1994-01-31 1995-01-31 Recombinant baculovirus and use thereof in the production of monoclonal antibodies

Country Status (8)

Country Link
EP (1) EP0742833B1 (en)
JP (1) JPH09511386A (en)
AT (1) ATE263251T1 (en)
AU (1) AU1582495A (en)
CA (1) CA2182380A1 (en)
DE (1) DE69532801T2 (en)
FR (1) FR2715664B1 (en)
WO (1) WO1995020672A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
EP1908769A1 (en) * 2001-08-27 2008-04-09 Genentech, Inc. A system for antibody expression and assembly
MXPA04001566A (en) * 2001-08-27 2004-05-17 Genentech Inc A system for antibody expression and assembly.
EA008247B1 (en) * 2002-09-27 2007-04-27 Паудерджект Рисерч Лимитед Nucleic acid constructs for gene expression
EP1532984A1 (en) 2003-11-19 2005-05-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of anti CD44 antibodies for eradicating stem cells in acute myeloid leukemia
JP2007519422A (en) 2004-02-02 2007-07-19 アンブレツクス・インコーポレイテツド Modified human four helix bundle polypeptides and their use
MXPA06014684A (en) 2004-06-18 2007-02-12 Ambrx Inc Novel antigen-binding polypeptides and their uses.
AU2005322019B2 (en) 2004-12-22 2010-08-26 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid
WO2006069246A2 (en) 2004-12-22 2006-06-29 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
BRPI0519430A2 (en) 2004-12-22 2009-02-10 Ambrx Inc modified human growth hormone
SG161210A1 (en) 2004-12-22 2010-05-27 Ambrx Inc Methods for expression and purification of recombinant human growth hormone
ATE541934T1 (en) 2004-12-22 2012-02-15 Ambrx Inc AMINOACYL TRNA SYNTHETASE COMPOSITIONS AND USES THEREOF
KR20080026135A (en) 2005-06-03 2008-03-24 암브룩스, 인코포레이티드 Improved human interferon molecules and their uses
FR2891552B1 (en) * 2005-10-05 2012-11-30 Agronomique Inst Nat Rech RECOMBINANT BACULOVIRUS EXPRESSING MULTIPLE GENES HETEROLOGISTS.
EP2339014B1 (en) 2005-11-16 2015-05-27 Ambrx, Inc. Methods and compositions comprising non-natural amino acids
NZ574721A (en) 2006-09-08 2012-02-24 Ambrx Inc Hybrid suppressor trna for vertebrate cells
EP2069396B1 (en) 2006-09-08 2015-10-21 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
US8420792B2 (en) 2006-09-08 2013-04-16 Ambrx, Inc. Suppressor tRNA transcription in vertebrate cells
BRPI0809583B1 (en) 2007-03-30 2022-02-22 Ambrx, Inc Modified fgf-21 polypeptide, composition comprising the same, method for producing said fgf-21 polypeptide, and cell comprising a polynucleotide
CA2685596A1 (en) 2007-05-02 2008-11-13 Ambrx, Inc. Modified interferon beta polypeptides and their uses
NZ603812A (en) 2007-11-20 2014-06-27 Ambrx Inc Modified insulin polypeptides and their uses
SG188143A1 (en) 2008-02-08 2013-03-28 Ambrx Inc Modified leptin polypeptides and their uses
NZ591235A (en) 2008-07-23 2012-07-27 Ambrx Inc Modified bovine g-csf polypeptides comprising non natural amino acid and their uses treating infections such as mastitis
PL2342223T3 (en) 2008-09-26 2017-09-29 Ambrx, Inc. Modified animal erythropoietin polypeptides and their uses
TR201802361T4 (en) 2008-09-26 2018-03-21 Ambrx Inc Microorganisms and vaccines dependent on unnatural amino acid replication.
NZ600361A (en) 2009-12-21 2014-06-27 Ambrx Inc Modified bovine somatotropin polypeptides and their uses
CN104017063A (en) 2009-12-21 2014-09-03 Ambrx公司 Modified porcine somatotropin polypeptides and their uses
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
MY162837A (en) 2010-08-17 2017-07-31 Ambrx Inc Modified relaxin polypeptides and their uses
AR083006A1 (en) 2010-09-23 2013-01-23 Lilly Co Eli FORMULATIONS FOR THE STIMULATING FACTOR OF COLONIES OF GRANULOCITS (G-CSF) BOVINE AND VARIANTS OF THE SAME
US9139863B2 (en) 2012-03-16 2015-09-22 Genentech, Inc. Engineered conformationally-stabilized proteins
US9791445B2 (en) 2013-01-28 2017-10-17 Kansas State University Research Foundation Rift Valley Fever Virus glycoproteins, Gn and Gc, and their use
UY36370A (en) 2014-10-24 2016-04-29 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware MODIFIED FGF-21 POLIPEPTIDES AND ITS USES
ES2963839T3 (en) 2017-02-08 2024-04-02 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2033070A1 (en) * 1989-05-17 1990-11-18 Lois K. Miller Baculovirus expression vectors
US5162222A (en) * 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
US5169784A (en) * 1990-09-17 1992-12-08 The Texas A & M University System Baculovirus dual promoter expression vector
EP1136562A3 (en) * 1991-11-08 2003-06-25 PHARMACIA & UPJOHN COMPANY Feline leukemia virus vaccines

Also Published As

Publication number Publication date
WO1995020672A1 (en) 1995-08-03
JPH09511386A (en) 1997-11-18
FR2715664A1 (en) 1995-08-04
EP0742833B1 (en) 2004-03-31
CA2182380A1 (en) 1995-08-03
ATE263251T1 (en) 2004-04-15
DE69532801D1 (en) 2004-05-06
FR2715664B1 (en) 1996-04-12
DE69532801T2 (en) 2005-03-17
EP0742833A1 (en) 1996-11-20

Similar Documents

Publication Publication Date Title
AU1582495A (en) Recombinant baculovirus and use thereof in the production of monoclonal antibodies
AU7575487A (en) Method for the preparation of proteins with factor VIII activity by microbial host cells; expression, vectors, host cells, antibodies
CA2114015A1 (en) Recombinant antibodies for human therapy
EP0670895A4 (en) Cloning, expression and uses of a novel secreted protein, f-spondin.
DE68917323D1 (en) Expression vector for fusion proteins and immunogen proteins.
EP0219106A3 (en) Polypeptides that elicit antibodies against aids virus
AU6174094A (en) Production of recombinant proteins containing multiple antigenic determinants linked by flexible hinge domains
DE3581578D1 (en) ANTIBODIES, PRODUCTION AND USE.
AU5233686A (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
AU6486196A (en) Novel factor viii:c polypeptide analogs with altered protease sites
AU572128B2 (en) New factor viii, coagulant polypeptides and monoclonal antibodies
NO910982L (en) URATOXYDASE-ACTIVE PROTEIN, RECOMBINANT GENE CODING IT, EXPRESSION VECTOR, MICROORGANISMS AND TRANSFORMER CELLS.
AU7657387A (en) Apoprotein b-100 specific monoclonal antibodies
AU3498795A (en) Method of blocking the sec receptor
AU3330689A (en) Monoclonal antibodies
EP0220063A3 (en) Anti-human interleukin 1 antibody, method for the production thereof and use of the same
PH31198A (en) Protein recognized by antibodies raised against native P28 of schitosoma mansoni.
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
CA2014948A1 (en) Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity
AU4375493A (en) Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof
AU5444386A (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and polyclonal)
DE3377220D1 (en) Recombinant dna, microorganism transformed therewith and use thereof
EP0255320A3 (en) Production of proteins in myeloma cells
DE69518290D1 (en) Grain growth process for the production of emulsions with high bromide, ultra-thin, tabular grain
AU7586387A (en) Polypeptide competitor for immunoglobulin e